Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by Calidi Biotherapeutics, Inc

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Tickers CLDI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.